WO2024220505A3 - Methods - Google Patents

Methods Download PDF

Info

Publication number
WO2024220505A3
WO2024220505A3 PCT/US2024/024942 US2024024942W WO2024220505A3 WO 2024220505 A3 WO2024220505 A3 WO 2024220505A3 US 2024024942 W US2024024942 W US 2024024942W WO 2024220505 A3 WO2024220505 A3 WO 2024220505A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
rna
location
determining
nucleic acid
Prior art date
Application number
PCT/US2024/024942
Other languages
French (fr)
Other versions
WO2024220505A2 (en
Inventor
Rabia KHAN
Michael Rushton
Original Assignee
Ladder Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ladder Therapeutics, Inc. filed Critical Ladder Therapeutics, Inc.
Publication of WO2024220505A2 publication Critical patent/WO2024220505A2/en
Publication of WO2024220505A3 publication Critical patent/WO2024220505A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/04—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amidines (3.5.4)
    • C12Y305/04001—Cytosine deaminase (3.5.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/04—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amidines (3.5.4)
    • C12Y305/04004—Adenosine deaminase (3.5.4.4)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2522/00—Reaction characterised by the use of non-enzymatic proteins
    • C12Q2522/10—Nucleic acid binding proteins
    • C12Q2522/101—Single or double stranded nucleic acid binding proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention provides advantageous methods for determining the location of the binding site of an RNA binding protein on a RNA nucleic acid.
PCT/US2024/024942 2023-04-18 2024-04-17 Methods WO2024220505A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363496906P 2023-04-18 2023-04-18
US63/496,906 2023-04-18

Publications (2)

Publication Number Publication Date
WO2024220505A2 WO2024220505A2 (en) 2024-10-24
WO2024220505A3 true WO2024220505A3 (en) 2025-02-13

Family

ID=93153472

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2024/024942 WO2024220505A2 (en) 2023-04-18 2024-04-17 Methods

Country Status (1)

Country Link
WO (1) WO2024220505A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100160174A1 (en) * 2002-08-05 2010-06-24 University Of Rochester Medical Center Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
WO2021183914A1 (en) * 2020-03-12 2021-09-16 The Regents Of The University Of California Methods and use of chimeric proteins

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100160174A1 (en) * 2002-08-05 2010-06-24 University Of Rochester Medical Center Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
WO2021183914A1 (en) * 2020-03-12 2021-09-16 The Regents Of The University Of California Methods and use of chimeric proteins

Also Published As

Publication number Publication date
WO2024220505A2 (en) 2024-10-24

Similar Documents

Publication Publication Date Title
AU2021289730A8 (en) BRM targeting compounds and associated methods of use
EP3805403A4 (en) Use of high-temperature-resistant cas protein, and method and reagent kit for detecting target nucleic acid molecule
WO2021247543A3 (en) Nucleic acid library methods
EP4471156A3 (en) Determining 5' transcript sequences
MX2023005301A (en) Brm targeting compounds and associated methods of use.
PH12021551114A1 (en) Crispr-cas12j enzyme and system
EP3981436A4 (en) Stable target-editing guide rna having chemically modified nucleic acid introduced thereinto
ZA202105895B (en) Inhibition of unintended mutations in gene editing
EP4471149A3 (en) Type v crispr-cas base editors and methods of use thereof
ATE507305T1 (en) METHOD FOR NUCLEIC ACID IMMOBILIZATION
WO2019241430A3 (en) Antibody-oligonucleotide conjugates
WO2007120859A3 (en) Methods for increasing accuracy of nucleic acid sequencing
TWI317811B (en)
DE69932813D1 (en) NUCLEIC BINDING PROTEIN
ATE514783T1 (en) PLASMID SYSTEM FOR EXPRESSING MULTIPLE GENES
MX2022007858A (en) CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE OF THESE.
EP4105644A3 (en) Systems and devices for sequence by synthesis analysis
WO2007070642A3 (en) Methods for increasing accuracy of nucleic acid sequencing
IL176479A0 (en) Methods and compositions for identifying rna-binding proteins
MX2021004602A (en) Genome editing by directed non-homologous dna insertion using a retroviral integrase-cas9 fusion protein.
EP4217364A4 (en) Methods of identifying protein binding sites on rna
WO2022046804A3 (en) Compositions and methods for assaying proteins and nucleic acids
EP3924515A4 (en) Methods for nucleic acid analysis
EP3871679A4 (en) Method for suppressing protein translation reaction using staple nucleic acid
EP4047091A4 (en) Method for detecting target nucleic acid, method for detecting nucleic acid-binding molecule, and method for evaluating nucleic acid-binding ability